News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
544,387 Results
Type
Article (58982)
Company Profile (153)
Press Release (485237)
Multimedia
Podcasts (90)
Webinars (16)
Section
Business (155345)
Career Advice (1394)
Deals (21472)
Drug Delivery (113)
Drug Development (67379)
Employer Resources (104)
FDA (10615)
Job Trends (10797)
News (238136)
Policy (19802)
Tag
2025 Best Places to Work (9)
2026 Best Places to Work (14)
2027 BioCapital Standard (4)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (2)
40 Under 40 (3)
Academia (2774)
Academic (1)
Accelerated approval (64)
ADA (34)
Adcomms (26)
Allergies (161)
Alliances (39369)
ALS (201)
Alzheimer's disease (1749)
Antibody-drug conjugate (ADC) (756)
Approvals (11199)
Artificial intelligence (816)
ASCO (346)
Autoimmune disease (427)
Automation (47)
Bankruptcy (154)
Belgium (28)
Best Places to Work (8390)
BIO (74)
Biologics (100)
BIOSECURE Act (11)
Biosimilars (189)
BioSpace Insights (96)
Biotechnology (110)
Bispecific (61)
Bladder cancer (252)
Brain cancer (104)
Breast cancer (987)
Cancer (8026)
Cardiovascular disease (402)
Career advice (1203)
Career pathing (39)
CAR-T (409)
CDC (42)
CDMO (142)
Celiac Disease (6)
Cell-line development (1)
Cell therapy (1011)
Cervical cancer (69)
Clinical research (59381)
Collaboration (2418)
Commercialization (47)
Company closure (8)
Compensation (833)
Complete response letters (74)
COVID-19 (2373)
CRISPR (130)
CRO (9)
C-suite (1212)
Cystic fibrosis (130)
Data (9375)
Decentralized trials (4)
Denatured (20)
Depression (148)
Dermatology (146)
Diabetes (526)
Diagnostics (6035)
Digital health (54)
Diversity (9)
Diversity, equity & inclusion (26)
Drug discovery (438)
Drug pricing (123)
Drug shortages (11)
Duchenne muscular dystrophy (269)
Earnings (56764)
Editorial (53)
Employer branding (17)
Employer resources (97)
ESMO (436)
Events (82515)
Executive appointments (955)
Eye disease (15)
FDA (14279)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (4)
Friedreich's ataxia (19)
Frontotemporal dementia (31)
Funding (1791)
Gene editing (233)
Generative AI (66)
Gene therapy (672)
GLP-1 (777)
Government (3088)
Grass and pollen (5)
Guidances (386)
Healthcare (13826)
Hematology (224)
HIV (97)
Huntington's disease (66)
Idiopathic pulmonary fibrosis (8)
IgA nephropathy (91)
Immunology and inflammation (242)
Immuno-oncology (159)
Indications (243)
Infectious disease (2690)
Inflammatory bowel disease (199)
Inflation Reduction Act (9)
Influenza (113)
Intellectual property (286)
Interviews (279)
IPO (10447)
IRA (36)
Job creations (2653)
Job search strategy (1003)
JPM (40)
Kidney cancer (31)
Kidney disease (135)
Labor market (101)
Layoffs (454)
Leadership (29)
Legal (3809)
Licensing (115)
Liver cancer (120)
Longevity (41)
Lung cancer (1118)
Lung diease (14)
Lymphoma (551)
Machine learning (65)
Management (34)
Manufacturing (1002)
Marketing (33)
MASH (210)
Medical affairs (4)
Medical device (7668)
Medtech (7841)
Melanoma (191)
Mergers & acquisitions (12091)
Metabolic disorders (1270)
Middle East (2)
mRNA (274)
Multiple sclerosis (202)
Multispecific (5)
NASH (12)
Netherlands (30)
Neurodegenerative disease (438)
Neuropsychiatric disorders (80)
Neuroscience (3320)
Neurotech (3)
NextGen: Class of 2026 (4121)
Non-profit (3979)
Now hiring (77)
Obesity (493)
Opinion (265)
Ovarian cancer (302)
Pain (219)
Pancreatic cancer (466)
Parkinson's disease (397)
Partnered (30)
Patents (561)
Patient advocacy (8)
Patient recruitment (767)
Patient selection (94)
Peanut (61)
People (43611)
Peptides (35)
Pharmaceutical (28)
Pharmacy benefit managers (17)
Phase 1 (19430)
Phase 2 (25724)
Phase 3 (19189)
Pipeline (11925)
Policy (259)
Postmarket research (2326)
Preclinical (9087)
Press Release (66)
Prostate cancer (415)
Psychedelics (58)
Radioligand (3)
Radiopharmaceuticals (427)
Rare diseases (1081)
Real estate (4473)
Recruiting (47)
Regenerative medicine (30)
Regulatory (18238)
Reports (53)
Research institute (2720)
Resumes & cover letters (199)
Rett syndrome (41)
RNA editing (25)
RSV (67)
Saudi Arabia (1)
Schizophrenia (155)
Series A (280)
Series B (184)
Series C (1)
Service/supplier (7)
Sickle cell disease (113)
Special edition (27)
Spinal muscular atrophy (137)
Sponsored (39)
Startups (2784)
State (1)
Stem cells (8)
Stomach cancer (25)
Substance use disorders (20)
Supply chain (83)
Switzerland (20)
Tariffs (54)
Tax incentives (1)
The Weekly (70)
Vaccines (1057)
Venture capital (109)
Weight loss (274)
Wet AMD (6)
Women's health (139)
Women in leadership (1)
Worklife (12)
Date
Today (38)
Last 7 days (513)
Last 30 days (2946)
Last 365 days (23746)
2026 (21860)
2025 (23189)
2024 (26780)
2023 (30812)
2022 (40951)
2021 (43124)
2020 (39357)
2019 (32719)
2018 (24652)
2017 (24337)
2016 (24223)
2015 (28583)
2014 (22042)
2013 (19243)
2012 (19353)
2011 (20094)
2010 (18965)
Location
Africa (643)
Alabama (94)
Alaska (4)
Arizona (238)
Arkansas (10)
Asia (33866)
Australia (6495)
California (12129)
Canada (3371)
China (1669)
Colorado (479)
Connecticut (566)
Delaware (387)
Europe (84268)
Florida (1818)
Georgia (402)
Hawaii (3)
Idaho (31)
Illinois (942)
India (110)
Indiana (574)
Iowa (31)
Japan (653)
Kansas (84)
Kentucky (45)
Louisiana (46)
Maine (25)
Maryland (1468)
Massachusetts (9819)
Michigan (281)
Minnesota (501)
Mississippi (4)
Missouri (130)
Montana (25)
Nebraska (19)
Nevada (126)
New Hampshire (63)
New Jersey (3490)
New Mexico (31)
New York (3554)
North Carolina (1551)
North Dakota (11)
Northern California (6417)
Ohio (339)
Oklahoma (20)
Oregon (28)
Pennsylvania (2200)
Puerto Rico (18)
Rhode Island (45)
South America (730)
South Carolina (44)
Southern California (4785)
Tennessee (159)
Texas (2181)
United States (43990)
Utah (286)
Vermont (2)
Virginia (288)
Washington D.C. (61)
Washington State (1151)
West Virginia (2)
Wisconsin (153)
Wyoming (4)
544,387 Results for "ximbio cancer research uk boston".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TrialAssure and Cancer Research UK Collaborate to Advance AI-Supported Regulatory Document Authoring
Cancer Research UK’s Centre for Drug Development is using TrialAssure LINK AI to support medical writing in CRUK-sponsored studies
June 18, 2026
·
1 min read
Press Releases
Cancer Research UK and Dewpoint Therapeutics partner to advance potential first-in-class MYC condensate modulator into clinical development
November 17, 2026
·
3 min read
Press Releases
TempraMed Signs Exclusive UK Distribution Agreement with Poole Bay Holdings for VIVI Epi(TM), Targeting School Networks Across the UK
Two-year agreement and approximately US$198,000 in potential purchases while opening established UK first-aid, medical-supply, workplace and education channels Highlights • Definitive agreement signed October 28, 2026 appoints Poole Bay Holdings Ltd. as exclusive UK distributor of VIVI Epi™ for an initial 24-month term, subject to UK regulatory requirements. • Contractual minimum purchase to maintain exclusivity. The initial two-year minimum volumes represent approximately US$198,000 in potential purchases. • Poole Bay Holdings reports 20 specialist e-commerce sites and more than 30,000 products, spanning first-aid, medical, health and safety, and workplace supplies. • Poole Bay has a network of 15,000 schools across the UK, and will be providing VIVI Epi to these locations • UK Food Standards Agency research estimates approximately 2.4 million adults have a clinically confirmed food allergy, highlighting the scale of allergy-management needs [1]. • The agreement provides for launch sampling, planned promotional activity and a framework to pursue institutional and consumer channels, subject to registrations and market adoption.
November 2, 2026
·
12 min read
Press Releases
Cancer Grand Challenges Researchers to Put AI Co-Scientists to the Test in Cancer Research
November 6, 2026
·
9 min read
Press Releases
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
October 6, 2026
·
6 min read
Press Releases
BostonGene Expands Scientific Collaboration with Leading Cancer Institute to Advance Breast Cancer Research
September 15, 2026
·
3 min read
Job Trends
7 companies hiring in Boston
Looking for a job in Boston? Here’s a list of 7 companies on
BioSpace
currently hiring biopharma roles in Boston–plus a few more hiring in Waltham and Weston.
June 18, 2026
·
1 min read
·
Chantal Dresner
Press Releases
Athernal Bio Secures Innovate UK Grant to Advance Cancer Interception in High-Risk Leukaemia
September 9, 2026
·
4 min read
Press Releases
BostonGene Showcases AI-Powered Multimodal Analytics at ESMO Congress 2025 to Advance Cancer Research and Drug Development
October 25, 2026
·
4 min read
Press Releases
Allegheny Health Network and The START Center for Cancer Research Announce Strategic Collaboration to Expand Patient Access to Early-Phase Cancer Trials
New START site to be established within AHN Cancer Center will integrate novel oncology research therapies closer to patients across Western Pennsylvania
August 25, 2026
·
1 min read
1 of 54,439
Next